Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.39 EUR | -0.76% |
|
+4.14% | -17.20% |
06-27 | The same old winners | ![]() |
06-26 | Mauna Kea Technologies SA Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.20% | 27.64M | |
-26.89% | 16.3B | |
-52.78% | 2.29B | |
+14.25% | 1.79B | |
-15.87% | 1.4B | |
+45.03% | 1.38B | |
+6.77% | 833M | |
-29.23% | 799M | |
-37.71% | 707M | |
-27.80% | 615M |
- Stock Market
- Equities
- ALMKT Stock
- News Mauna Kea Technologies
- Mauna Kea Technologies SA announced that it has received €7.499999 million in funding from Johnson & Johnson Innovation - JJDC, Inc.